Weihai Baihe Biology Technological603102.SHValuation Analysis

As of Oct 19, 2026, Weihai Baihe Biology Technological (603102.SH) trades at a P/E of 19.30x, P/B of 1.34x, P/S of 2.28x, and a dividend yield of 2.04%.
Longitudinal percentile comparison: P/E sits at the 63rd percentile over the trailing 10Y window (vs. 59th percentile over 3Y); P/B sits at the 12th percentile over the trailing 10Y window (vs. 19th percentile over 3Y); P/S sits at the 8th percentile over the trailing 10Y window (vs. 12th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 32nd percentile within its industry and the 23rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 3.35%, ranking at the 75th percentile over the trailing 20Y window.
Notably, P/E and P/B aren't telling quite the same story, 50.4 points apart — worth checking the full percentile matrix on this page for the complete picture. The P/E percentile sits lower across the market than within its own industry — relatively cheaper next to the market as a whole. Of the 3.35% total shareholder yield, 2.04% is paid out as dividends and roughly 1.31% is implied to come from buybacks — both channels are meaningfully in play. Weihai Baihe Biology Technological operates in the Food and Beverage sector. Data refreshes weekly and is for reference only, not investment advice.